VFRM stock falls to $0.0001: Veritas Farms (VFRM, PNK) top loser, watch liquidity
VFRM stock plunged to $0.0001 in U.S. regular trading on 15 Jan 2026, making Veritas Farms, Inc. (VFRM) one of the top losers on the PNK exchange. The move erased nearly -99.90% versus the reported previous close. Low liquidity and a tiny market cap of $16,388.00 USD amplified the drop. We examine why the price collapsed, the company’s key financial ratios, and what our model and grade say about short- and medium-term prospects for Veritas Farms, Inc.
VFRM stock: Market snapshot and session data
Veritas Farms, Inc. (VFRM) traded at $0.0001 on 15 Jan 2026 during U.S. market hours on the PNK exchange. Volume was 1,142.00 shares versus an average volume of 3,359.00, showing very low liquidity. The reported market cap is $16,388.00 USD and shares outstanding are 163,879,870.00. The company operates in the Healthcare sector, specifically Drug Manufacturers – Specialty & Generic, and reports financials in USD. For a quick company profile, see the Veritas Farms website and our Meyka page for live updates Meyka VFRM page.
VFRM stock: Why the price collapsed
The abrupt fall reflects a massive value reset from a prior quoted close of $0.10005 to $0.0001. That gap suggests either an adjustment, a quote correction, or a liquidity-driven freefall on the over-the-counter market. Low float and thin trading magnify single-session moves. Market participants should note the risk of reporting corrections and possible reverse splits or delisting actions. For a competitor comparison and market context, see this recent market page source.
VFRM stock: Financials, valuation and fundamentals
Veritas Farms reports negative earnings with EPS -0.12 USD and no meaningful P/E ratio. Key ratios show price-to-sales at 0.02 and book value per share at -0.01 USD, indicating negative equity. Enterprise value is $4,547,742.00 USD, far above market cap, signaling capital structure and reporting anomalies. Cash per share is 0.00 USD and free cash flow per share is -0.09 USD. These metrics point to weak fundamentals and high structural risk for shareholders.
Meyka AI rates VFRM with a score out of 100: 58.78 (C+, HOLD). This grade factors S&P 500 comparison, sector and industry metrics, financial growth, key ratios, forecasts, analyst consensus, and fundamental growth. These results do not guarantee outcomes and are not investment advice.
VFRM stock: Technicals and trading metrics
Technical indicators show muted momentum on thin volume. The 14-day RSI is 46.33, near neutral. ADX at 90.63 indicates a strong trend but that reflects price collapse, not upward conviction. Price averages are tiny: 50-day average price 0.00011 USD and 200-day average 0.00017 USD. On-chain or short-interest data is limited, and on-balance volume is negative, at -82,324.00, consistent with selling pressure.
VFRM stock: Risks, catalysts and sector context
Primary risks are extreme illiquidity, negative equity, long cash conversion cycles, and thin public reporting. Debt metrics show interest coverage of -11.25, raising refinancing concerns. Catalysts would include renewed product demand, a meaningful distribution agreement, or capital raises that stabilize the balance sheet. Sector trends in cannabis and hemp-derived products remain mixed, and Veritas Farms faces strong competition from larger peers in Healthcare and Drug Manufacturing.
VFRM stock: Price targets and Meyka AI forecast
Meyka AI’s forecast model projects a conservative 12-month base case target of $0.0010 USD for Veritas Farms, Inc. compared with the current price of $0.0001 USD, implying a model-based upside of +900.00%. A cautious bear case is $0.00005 USD, implying -50.00% downside. These targets reflect scenario-based modeling, not guaranteed outcomes. Forecasts are model-based projections and not guarantees.
Final Thoughts
VFRM stock trades as a highly speculative microcap with severe liquidity and balance-sheet risks. The immediate cause of the sharp fall is low trading depth and a likely quote correction from a prior close of $0.10005 to $0.0001 USD. Financials show EPS -0.12 USD, negative book value, and weak cash metrics, supporting a conservative stance. Meyka AI rates VFRM 58.78/100 (C+, HOLD) and the model projects a 12-month base case of $0.0010 USD, implying +900.00% versus the current price. That forecast assumes operational stabilizers or capital injections. Traders should treat VFRM as a liquidity-driven, high-risk holding. Use limit orders and size positions carefully. For continuous updates and alerts on Veritas Farms, see our Meyka AI-powered market analysis and the company comparison page source. Forecasts are model-based projections and not guarantees.
FAQs
What caused the large drop in VFRM stock price?
The sharp fall stems from extreme illiquidity, a likely quote adjustment from $0.10005 to $0.0001 USD, and thin trading on the PNK market. Low float magnified the move.
Is VFRM stock a buy after the collapse?
VFRM stock is high risk. Meyka AI gives a C+ (HOLD). Only consider small, speculative stakes after due diligence and confirmation of company filings or financing.
What are the key financial red flags for VFRM stock?
Red flags include negative book value, EPS -0.12 USD, free cash flow per share -0.09 USD, and negative interest coverage of -11.25, indicating tight liquidity.
What upside does the Meyka forecast show for VFRM stock?
Meyka AI’s forecast model projects $0.0010 USD in 12 months from $0.0001 USD now, implying roughly +900.00%, but forecasts are not guarantees.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
